Merck Healthcare KGaA
Katharina is a biologist by training. She received her doctoral degree working on protein biochemistry and molecular tumour biology. To start her regulatory medical writing career, she joined Boehringer Ingelheim as a Medical Writer. Afterwards Katharina joined the Regulatory Writing & Submissions team of Sandoz, a Novartis division and continued working as a Regulatory Medical Writer, writing and managing submission documents for biosimilar as well as innovative medicine submissions. In 2021, she continued her medical writing career at Merck. Over the years, Katharina has been involved in writing and managing documents across various stages of clinical development and across various therapeutic areas and indications, including both biosimilar and innovative medicine development programs.